» Articles » PMID: 36762954

Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes

Overview
Journal J Immunol
Date 2023 Feb 10
PMID 36762954
Authors
Affiliations
Soon will be listed here.
Abstract

IL-21 is essential for type 1 diabetes (T1D) development in the NOD mouse model. IL-21-expressing CD4 T cells are present in pancreatic islets where they contribute to T1D progression. However, little is known about their phenotype and differentiation states. To fill this gap, we generated, to our knowledge, a novel IL-21 reporter NOD strain to further characterize IL-21+ CD4 T cells in T1D. IL-21+ CD4 T cells accumulate in pancreatic islets and recognize β cell Ags. Single-cell RNA sequencing revealed that CD4 T effector cells in islets actively express IL-21 and they are highly diabetogenic despite expressing multiple inhibitory molecules, including PD-1 and LAG3. Islet IL-21+ CD4 T cells segregate into four phenotypically and transcriptionally distinct differentiation states, that is, less differentiated early effectors, T follicular helper (Tfh)-like cells, and two Th1 subsets. Trajectory analysis predicts that early effectors differentiate into both Tfh-like and terminal Th1 cells. We further demonstrated that intrinsic IL-27 signaling controls the differentiation of islet IL-21+ CD4 T cells, contributing to their helper function. Collectively, our study reveals the heterogeneity of islet-infiltrating IL-21+ CD4 T cells and indicates that both Tfh-like and Th1 subsets produce IL-21 throughout their differentiation process, highlighting the important sources of IL-21 in T1D pathogenesis.

Citing Articles

Polyfunctional IL-21 IFNG T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy.

Huang N, Ortega J, Kimbrell K, Lee J, Scott L, Peluso E bioRxiv. 2024; .

PMID: 39677814 PMC: 11642801. DOI: 10.1101/2024.11.27.625710.


A pathologically expanded, clonal lineage of IL-21-producing CD4+ T cells drives inflammatory neuropathy.

Seyedsadr M, Bang M, McCarthy E, Zhang S, Chen H, Mohebbi M J Clin Invest. 2024; 134(15).

PMID: 39087473 PMC: 11290969. DOI: 10.1172/JCI178602.


IL-27 promotes pathogenic T cells in a mouse model of Sjögren's disease.

Debreceni I, Barr J, Upton E, Chen Y, Lieberman S Clin Immunol. 2024; 264:110260.

PMID: 38788885 PMC: 11203157. DOI: 10.1016/j.clim.2024.110260.


A pathologically expanded, clonal lineage of IL-21 producing CD4+ T cells drives Inflammatory neuropathy.

Seyedsadr M, Bang M, McCarthy E, Zhang S, Chen H, Mohebbi M bioRxiv. 2024; .

PMID: 38260637 PMC: 10802410. DOI: 10.1101/2024.01.07.574553.


Deletion of Vβ3CD4 T cells by endogenous mouse mammary tumor virus 3 prevents type 1 diabetes induction by autoreactive CD8 T cells.

Ye C, Clements S, Gu W, Geurts A, Mathews C, Serreze D Proc Natl Acad Sci U S A. 2023; 120(49):e2312039120.

PMID: 38015847 PMC: 10710095. DOI: 10.1073/pnas.2312039120.

References
1.
von Herrath M, Bain S, Bode B, Clausen J, Coppieters K, Gaysina L . Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2021; 9(4):212-224. DOI: 10.1016/S2213-8587(21)00019-X. View

2.
Ferreira R, Simons H, Thompson W, Cutler A, Dopico X, Smyth D . IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia. 2015; 58(4):781-90. PMC: 4351433. DOI: 10.1007/s00125-015-3509-8. View

3.
Zander R, Kasmani M, Chen Y, Topchyan P, Shen J, Zheng S . Tfh-cell-derived interleukin 21 sustains effector CD8 T cell responses during chronic viral infection. Immunity. 2022; 55(3):475-493.e5. PMC: 8916994. DOI: 10.1016/j.immuni.2022.01.018. View

4.
Clough L, Wang C, Schmidt E, Booth G, Hou T, Ryan G . Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J Immunol. 2008; 180(8):5393-401. DOI: 10.4049/jimmunol.180.8.5393. View

5.
Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y . Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017; 542(7639):110-114. PMC: 5349321. DOI: 10.1038/nature20810. View